Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 16/20 | 0.47 |
| ▸ | RXRG | P48443 | 8/20 | 0.46 |
| ▸ | RXRB | P28702 | 7/20 | 0.46 |
| ▸ | RARA | P10276 | 4/20 | 0.46 |
| ▸ | RARB | P10826 | 3/20 | 0.46 |
| ▸ | RARG | P13631 | 3/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | CYP26A1 | O43174 | 4/20 | 0.44 |
| ▸ | CYP26B1 | Q9NR63 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23927691 | 0.79 | RXRA (0.41) | RXRARXRGRXRBRARARARB | |
| SCHEMBL8459822 | 0.79 | RARB (0.65) | RXRARXRGRXRBRARARARB | |
| SCHEMBL23439466 | 0.78 | RXRA (0.38) | RXRARXRGRXRBRARARARB | |
| SCHEMBL26592538 | 0.77 | RXRA (0.44) | RXRARXRGRXRBRARARARB | |
| SCHEMBL330467 | 0.74 | KCNMA1 (0.57) | MEN1ADRA2ABLMKMT2A | |
| SCHEMBL7622765 | 0.73 | RXRA (0.48) | RXRARXRGRXRBRARARARB | |
| SCHEMBL22836804 | 0.72 | RXRA (0.62) | RXRARXRGRXRBRARARARB | |
| SCHEMBL7218238 | 0.72 | RXRA (0.73) | RXRARXRGRXRBRARARARB | |
| SCHEMBL17049086 | 0.70 | CYP3A4 (0.51) | RXRARXRGRXRBRARARARB | |
| SCHEMBL5180614 | 0.70 | RXRA (0.54) | RXRARXRGRXRBRARARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792241-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | Takasago International Corporation (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
| WO-2019216355-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | 高砂香料工業株式会社 (JP) | 2019-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | ADH1C, CBR1, NAP1L4 | RXRA 903/4885RXRG 247/4885RXRB 1054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.